September 19, 2020 9:40 PM
Tata CRISPR test, powered by CSIR-IGIB FELUDA, receives regulatory approvals from DCGI for commercial launch
<span style="color: #222222;">The Tata Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR test, powered by CSIR-Institute of Genomics and Integrative Biology, IGIB FELUDA today received regulatory approvals from the Drug Controller General of India, DCGI for commercial launch. <br />''<br />''As per ICMR guidelines, it has met high quality benchmarks with 96 per cent sensitivity and 98 per cent specificity for detecting the novel Coronavirus. T...